Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
These advancements have significantly improved the quality of life for millions of people with diabetes worldwide
In the pancreas, they enhance glucose-dependent insulin secretion and suppress glucagon release, improving blood sugar control with a low risk of hypoglycemia when used alone (though risk increases when combined with insulin or sulfonylureas)
Approximately 90% of more than 37 million Americans with diabetes have Type 2 diabetes, a condition commonly associated with obesity, as reported by the CDC
[PubMed] [CrossRef] Magoulas PL, El-Hattab AW
BPC-157 is a synthetic peptide investigated in preclinical and animal research for tissue-repair signaling, angiogenesis, and gut-lining studies
